Objectives:
- Review the immune response to malignancy, with a focus on what is known of the immune response to lymphoma
- Discuss known mechanisms of immune surveillance escape and exploitation with immunotherapy
- Review clinical evidence for current use of immunotherapy for NHL and identify future research directions
Session date:
Monday, July 23, 2018 - 12:00pm to 1:00pm
Location:
UCMC
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Michael Leukam MD